| Financial Year |
March 31 2023 |
| Monetary Funds |
701,131,093.93 |
| Held-for-trading Financial Assets |
105,897,329.59 |
| Notes Receivable |
514,676,075.77 |
| Accounts Receivable |
934,803,763.48 |
| Advances to Suppliers |
49,791,471.16 |
| Other Receivables |
32,579,199.44 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
885,153,225.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
151,001,837.82 |
| Total Current Assets |
3,649,251,466.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,837,938.05 |
| Investment Properties |
-- |
| Fixed Assetes |
830,745,291.43 |
| Under-construction Projects |
34,560,956.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
115,907,612.10 |
| R&D expenses |
-- |
| Goodwill |
50,232,290.36 |
| Long-Term Deferred and Prepaid Expenses |
10,610,332.56 |
| Deferred Income Tax Assets |
69,322,195.39 |
| Other Non-Current Assets |
69,418,467.96 |
| Sub-Total of Non-Current Assets |
1,336,041,158.99 |
| Total Assets |
4,985,292,625.98 |
| Short-Term Loans |
191,756,835.45 |
| Trading Financial liabilities |
555,383.44 |
| Notes Payable |
328,136,322.78 |
| Accounts Payable |
756,329,073.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
208,202,804.71 |
| Taxes Payable |
16,069,936.01 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
88,104,658.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,086,936.33 |
| Other Current Liabilities |
434,160,059.64 |
| Sub-Total of Current Liabilities |
2,183,759,116.56 |
| Long-term Loans |
273,133,333.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
588,601.94 |
| Special Payable |
-- |
| Estimatied Liabilities |
21,042,690.27 |
| Deferred Income Tax Liabilities |
54,112.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
354,670,445.91 |
| Total Liabilities |
2,538,429,562.47 |
| Paid-In Capital(Or Share Stock) |
793,430,710.00 |
| Capital Surplus |
280,420,458.80 |
| Surplus Reserve |
193,073,331.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,151,816,236.40 |
| Minority Stockholder's Interest |
26,767,618.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,420,095,445.35 |
| Owner's Equity（Stockholder's Equity） |
2,446,863,063.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,985,292,625.98 |
